501477.BO Stock Analysis
50
Avoid
Based on Eyestock quantitative analysis, 501477.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Muller & Phipps (India) Ltd. engages in provision of distribution and marketing services. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-08-10. The Company’s segment includes Cosmetics/Toiletries, Medicated preparation and food products. The firm's products/services include medicated dental products, ayurvedic skin ointment and home care products. Its medicated dental products include cavisan and cavifast. The firm's ayurvedic skin ointment product is Nixoderm. Its home care product is Alfa Plus. Its wholly owned subsidiaries include Muller and Phipps (Industrial Services) Ltd. and Muller and Phipps Agencies Ltd.